Sign Up Today and Learn More About OrsoBio Stock
Invest in or calculate the value of your shares in OrsoBio or other pre-IPO companies through EquityZen's platform.
OrsoBio Stock (ORSB)
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
About OrsoBio Stock
Founded
2021
Headquarters
Palo Alto, CA, US
Industries
Artificial Intelligence, Software, Data and Analytics
OrsoBio Press Mentions
Stay in the know about the latest news on OrsoBio
OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
biospace • Jun 15, 2026
OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
morningstar • Jun 15, 2026
OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
businesswire • Jun 15, 2026
OrsoBio posts promising tirzepatide combo data
longevity • Jun 13, 2026
OrsoBio drug combo boosts weight loss by an extra 4.5% in early trial
longevity • Jun 08, 2026
OrsoBio Management
Leadership team at OrsoBio
Board of Director
Evan Rachlin
Board Member
Edd Fleming
Join now and verify your accreditation status to gain access to:
- OrsoBio Current Valuation
- OrsoBio Stock Price
- OrsoBio Management
- Available deals in OrsoBio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- OrsoBio Cap Table and Funding History by Share Class and Liquidity Preferences
- OrsoBio Revenue and Financials
- OrsoBio Highlights
- OrsoBio Business Model
- OrsoBio Risk Factors
- OrsoBio Research Report from SACRA Research
Trading OrsoBio Stock
How to invest in OrsoBio stock?
Accredited investors can buy pre-IPO stock in companies like OrsoBio through EquityZen funds. These investments are made available by existing OrsoBio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell OrsoBio stock?
Shareholders can sell their OrsoBio stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
